A Phase 2 Study to Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects.

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 128 participants.

Also called NCT03848793

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 128 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03848793
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03848793. Randomized; quadruple masking; primary purpose treatment. Start 2019-03-06 (actual); primary completion 2020-06-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Phase 2 Study to Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects.
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
HS-20004
Lead sponsor
Jiangsu HengRui Medicine Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct03848793
Content hash
ba824af4ad6cf59f55cfe99425aa27c37f11187710bcd053512d8597d2fddba6